IL6 and influenza: Our data support this latter conclusion, as do our earlier studies, which showed a correlation between increased BALF IL-6 at 6 d.p.i. and amelioration of ALI following treatment of influenza-infected WT mice with the de novo pyrimidine synthesis inhibitor A77-1726 (2).